Filter the latest scan's published facts — sector, size, yield, valuation — or rank them with a preset: cheapest, fastest growing, most profitable. Every view shows what is in the filings and prices; none ranks opportunity. The model behind the statuses showed no predictive power, and nothing here is a recommendation.
Scan of 2026-08-31 · 2,409 names scored · prices as of that date
Lowest valid-in-sector trailing valuation multiples today, latest scan: each name's sector percentiles on earnings yield, FCF yield, P/S, P/B, P/TBV and P/CFO, averaged (only the metrics valid in its sector — a REIT is never ranked by GAAP P/E here). “Cheapest” is a fact about trailing multiples versus sector peers, not a forecast that they re-rate.
Tested the unforgiving way: a composite ranking built from these same point-in-time filings (2017-01-31 to 2026-05-29) showed no measurable predictive power (mean IC 0.0168, t = 1.21), and its top quintile did not beat holding everything even before costs. Ranks like these describe today's record; they do not predict tomorrow's return.
180 names — page 4 of 4 · sector: Healthcare · Export CSV
| # | Ticker | Company | Sector | Cheap composite | P/E (trailing) | P/S (trailing) | FCF yield | Own 5y |
|---|---|---|---|---|---|---|---|---|
| 151 | CBLL | CeriBell, Inc. Common Stock | Healthcare | 25.2 | — | 9.5× | -5.4% | — |
Never the absolute multiple alone. A P/E of 9 is a fact; whether it is low depends on what you hold it against.
The five-year window is the empirically privileged one. Cheap against its sector and cheap against its own history are different claims, and a stock can be one without being the other — which is the whole reason both columns are shown rather than blended into a single score.
| 152 | CAI | Caris Life Sciences, Inc. Common Stock | Healthcare | 24.7 | 212× | 7.9× | 1.7% | — |
| 153 | TXG | 10x Genomics, Inc. Class A Common Stock | Healthcare | 24.3 | — | 12.5× | 1.5% | +1.0σ |
| 154 | FEIM | Frequency Electronics, Inc. | Healthcare | 24.2 | 82.4× | 8.7× | -0.2% | −0.7σ |
| 155 | ILMN | Illumina Inc | Healthcare | 24.1 | 50.3× | 9.8× | 2.3% | +0.3σ |
| 156 | SGHT | Sight Sciences, Inc. Common Stock | Healthcare | 23.9 | — | 5.8× | -5.5% | +0.9σ |
| 157 | KEYS | Keysight Technologies, Inc. | Healthcare | 23.8 | 62.1× | 10.7× | 2.1% | −1.8σ |
| 158 | SMTI | Sanara MedTech Inc. Common Stock | Healthcare | 23.4 | — | 3.0× | 1.1% | +2.2σ |
| 159 | PSNL | Personalis, Inc. Common Stock | Healthcare | 22.9 | — | 27.2× | -4.8% | +0.9σ |
| 160 | XGN | Exagen Inc. Common Stock | Healthcare | 22.9 | — | 2.6× | -8.0% | +0.9σ |
| 161 | ESTA | Establishment Labs Holdings Inc. | Healthcare | 21.7 | — | 8.9× | -2.0% | +0.8σ |
| 162 | WGS | GeneDx Holdings Corp. Class A Common Stock | Healthcare | 21.4 | — | 5.7× | -1.1% | +0.6σ |
| 163 | IRTC | iRhythm Holdings, Inc. Common Stock | Healthcare | 20.7 | — | 5.0× | 0.5% | +1.3σ |
| 164 | TER | Teradyne, Inc. Common Stock | Healthcare | 20.2 | 64.1× | 14.5× | 1.0% | −1.2σ |
| 165 | BDSX | Biodesix, Inc. Common Stock | Healthcare | 20.2 | — | 2.8× | -9.4% | +1.3σ |
| 166 | BFLY | Butterfly Network, Inc. | Healthcare | 19.6 | — | 20.0× | -0.9% | +1.0σ |
| 167 | AXGN | Axogen, Inc. Common Stock | Healthcare | 19.5 | — | 11.3× | 0.3% | +1.2σ |
| 168 | FCUV | Focus Universal Inc. Common Stock | Healthcare | 19.2 | — | 89.6× | -50.1% | −0.2σ |
| 169 | OBIO | Orchestra BioMed Holdings, Inc. Ordinary Shares | Healthcare | 19.1 | — | 9.0× | -18.6% | −0.1σ |
| 170 | SPAI | Safe Pro Group Inc. Common Stock | Healthcare | 18.8 | — | 66.2× | -6.0% | — |
| 171 | NPCE | Neuropace, Inc. Common Stock | Healthcare | 17.4 | — | 5.0× | -2.0% | +0.8σ |
| 172 | AEHR | Aehr Test Systems | Healthcare | 16.5 | — | 54.2× | -0.7% | +0.0σ |
| 173 | GKOS | Glaukos Corporation | Healthcare | 16.4 | — | 19.0× | -0.2% | +1.2σ |
| 174 | HTFL | Heartflow, Inc. Common Stock | Healthcare | 15.8 | — | 22.7× | -1.8% | — |
| 175 | OPTX | Syntec Optics Holdings, Inc. Class A Common Stock | Healthcare | 13.8 | — | 11.0× | 0.0% | +0.6σ |
| 176 | NTRA | Natera, Inc. Common Stock | Healthcare | 13.6 | — | 18.4× | 0.2% | +1.0σ |
| 177 | PLSE | Pulse Biosciences, Inc Common Stock (DE) | Healthcare | 13.4 | — | — | -1.6% | +0.6σ |
| 178 | SENS | Senseonics Holdings, Inc. Common Stock | Healthcare | 12.5 | — | 9.5× | -19.8% | −0.1σ |
| 179 | CLPT | ClearPoint Neuro, Inc. Common Stock | Healthcare | 11.8 | — | 11.2× | -5.9% | +0.0σ |
| 180 | CELC | Celcuity Inc. Common Stock | Healthcare | 9.9 | — | — | -4.0% | +1.1σ |
"Cheap composite" is a 0–100 position among valid sector peers — the mean of the component metrics' sector percentiles. "—" means the scan published no figure, deliberately. "n/a — masked" means the metric is misleading in that name's sector (a REIT's GAAP P/E, a bank's FCF yield) — hover for the reason, which comes from the same sector-validity rules the composite itself respects. An FY tag marks a trailing-year figure built from an annual filing; hover for what that means.